Related references
Note: Only part of the references are listed.Glioma progression is shaped by genetic evolution and microenvironment interactions
Frederick S. Varn et al.
CELL (2022)
Effectiveness of Lomustine Combined With Bevacizumab in Glioblastoma: A Meta-Analysis
Xing Ren et al.
FRONTIERS IN NEUROLOGY (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Chinese Glioma Genome Atlas (CGGA) : A Comprehensive Resource with Functional Genomic Data from Chinese Glioma Patients
Zheng Zhao et al.
GENOMICS PROTEOMICS & BIOINFORMATICS (2021)
Fc gamma RIIB is a T cell checkpoint in antitumor immunity
Clara R. Farley et al.
JCI INSIGHT (2021)
Single-cell profiling of myeloid cells in glioblastoma across species and disease stage reveals macrophage competition and specialization
Ana Rita Pombo Antunes et al.
NATURE NEUROSCIENCE (2021)
Prognostic significance of FCGR2B expression for the response of DLBCL patients to rituximab or obinutuzumab treatment
Malgorzata Nowicka et al.
BLOOD ADVANCES (2021)
Interrogation of the Microenvironmental Landscape in Brain Tumors Reveals Disease-Specific Alterations of Immune Cells
Florian Klemm et al.
CELL (2020)
An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma
Cyril Neftel et al.
CELL (2019)
LinkedOmics: analyzing multi-omics data within and across 32 cancer types
Suhas V. Vasaikar et al.
NUCLEIC ACIDS RESEARCH (2018)
Role of Fc-FcγR interactions in the antitumor activity of therapeutic antibodies
Bryan C. Barnhart et al.
IMMUNOLOGY AND CELL BIOLOGY (2017)
Lomustine and Bevacizumab in Progressive Glioblastoma
Wolfgang Wick et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment
Qianghu Wang et al.
CANCER CELL (2017)
Antagonistic Human FcγRIIB (CD32B) Antibodies Have Anti-Tumor Activity and Overcome Resistance to Antibody Therapy In Vivo
Ali Roghanian et al.
CANCER CELL (2015)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
The Somatic Genomic Landscape of Glioblastoma
Cameron W. Brennan et al.
CELL (2013)
The Inhibiting Fc Receptor for IgG, FcγRIIB, Is a Modifier of Autoimmune Susceptibility
Peter Boross et al.
JOURNAL OF IMMUNOLOGY (2011)
Adjuvant Trastuzumab in HER2-Positive Breast Cancer
Dennis Slamon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Inhibitory Fcγ Receptor Engagement Drives Adjuvant and Anti-Tumor Activities of Agonistic CD40 Antibodies
Fubin Li et al.
SCIENCE (2011)
A defunctioning polymorphism in FCGR2B is associated with protection against malaria but susceptibility to systemic lupus erythematosus
Lisa C. Willcocks et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Fc gamma RIIB in autoimmunity and infection: evolutionary and therapeutic implications
Kenneth G. C. Smith et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Fc gamma RIIB in autoimmunity and infection: evolutionary and therapeutic implications (vol 10, pg 328, 2010)
Kenneth G. C. Smith et al.
NATURE REVIEWS IMMUNOLOGY (2010)
ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks
Gabriela Bindea et al.
BIOINFORMATICS (2009)
Rembrandt: Helping Personalized Medicine Become a Reality through Integrative Translational Research
Subha Madhavan et al.
MOLECULAR CANCER RESEARCH (2009)
Fc gamma receptors as regulators of immune responses
Falk Nimmerjahn et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Monoclonal antibody therapy of cancer
GP Adams et al.
NATURE BIOTECHNOLOGY (2005)
Fcγ receptor IIB-deficient mice develop Goodpasture's syndrome upon immunization with type IV collagen:: A novel murine model for autoimmune glomerular basement membrane disease
A Nakamura et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets
RA Clynes et al.
NATURE MEDICINE (2000)
KEGG: Kyoto Encyclopedia of Genes and Genomes
M Kanehisa et al.
NUCLEIC ACIDS RESEARCH (2000)